149 related articles for article (PubMed ID: 12490548)
1. Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells.
Shadidi M; Sioud M
FASEB J; 2003 Feb; 17(2):256-8. PubMed ID: 12490548
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide.
Tan M; Lan KH; Yao J; Lu CH; Sun M; Neal CL; Lu J; Yu D
Cancer Res; 2006 Apr; 66(7):3764-72. PubMed ID: 16585203
[TBL] [Abstract][Full Text] [Related]
3. Selection of tumor-specific internalizing human antibodies from phage libraries.
Poul MA; Becerril B; Nielsen UB; Morisson P; Marks JD
J Mol Biol; 2000 Sep; 301(5):1149-61. PubMed ID: 10966812
[TBL] [Abstract][Full Text] [Related]
4. Screening and identification of a peptide specifically targeted to NCI-H1299 from a phage display peptide library.
Zang L; Shi L; Guo J; Pan Q; Wu W; Pan X; Wang J
Cancer Lett; 2009 Aug; 281(1):64-70. PubMed ID: 19327883
[TBL] [Abstract][Full Text] [Related]
5. Selection of peptides for specific delivery of oligonucleotides into cancer cells.
Shadidi M; Sioud M
Methods Mol Biol; 2004; 252():569-80. PubMed ID: 15017081
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial discovery of tumor targeting peptides using phage display.
Landon LA; Deutscher SL
J Cell Biochem; 2003 Oct; 90(3):509-17. PubMed ID: 14523985
[TBL] [Abstract][Full Text] [Related]
7. A new daunomycin-peptide conjugate: synthesis, characterization and the effect on the protein expression profile of HL-60 cells in vitro.
Orbán E; Manea M; Marquadt A; Bánóczi Z; Csík G; Fellinger E; Bosze S; Hudecz F
Bioconjug Chem; 2011 Oct; 22(10):2154-65. PubMed ID: 21950465
[TBL] [Abstract][Full Text] [Related]
8. Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice.
Sato N; Kobayashi H; Saga T; Nakamoto Y; Ishimori T; Togashi K; Fujibayashi Y; Konishi J; Brechbiel MW
Clin Cancer Res; 2001 Nov; 7(11):3606-12. PubMed ID: 11705883
[TBL] [Abstract][Full Text] [Related]
9. Binding motifs of CBP2 a potential cell surface target for carcinoma cells.
Sauk JJ; Coletta RD; Norris K; Hebert C
J Cell Biochem; 2000 May; 78(2):251-63. PubMed ID: 10842320
[TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of antisense oligonucleotides and siRNAs into mammalian cells.
Sioud M
Methods Mol Biol; 2009; 487():61-82. PubMed ID: 19301642
[TBL] [Abstract][Full Text] [Related]
11. A novel peptide probe for imaging and targeted delivery of liposomal doxorubicin to lung tumor.
He X; Na MH; Kim JS; Lee GY; Park JY; Hoffman AS; Nam JO; Han SE; Sim GY; Oh YK; Kim IS; Lee BH
Mol Pharm; 2011 Apr; 8(2):430-8. PubMed ID: 21222482
[TBL] [Abstract][Full Text] [Related]
12. Tumor cell-targeting by phage-displayed peptides.
Rasmussen UB; Schreiber V; Schultz H; Mischler F; Schughart K
Cancer Gene Ther; 2002 Jul; 9(7):606-12. PubMed ID: 12082461
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel peptide ligand of human vascular endothelia growth factor receptor 3 for targeted tumour diagnosis and therapy.
Qin X; Wan Y; Li M; Xue X; Wu S; Zhang C; You Y; Wang W; Jiang C; Liu Y; Zhu W; Ran Y; Zhang Z; Han W; Zhang Y
J Biochem; 2007 Jul; 142(1):79-85. PubMed ID: 17517791
[TBL] [Abstract][Full Text] [Related]
14. targeted drug delivery to hepatocarcinoma in vivo by phage-displayed specific binding peptide.
Du B; Han H; Wang Z; Kuang L; Wang L; Yu L; Wu M; Zhou Z; Qian M
Mol Cancer Res; 2010 Feb; 8(2):135-44. PubMed ID: 20145035
[TBL] [Abstract][Full Text] [Related]
15. Neuroblastoma tumor cell-binding peptides identified through random peptide phage display.
Zhang J; Spring H; Schwab M
Cancer Lett; 2001 Oct; 171(2):153-64. PubMed ID: 11520599
[TBL] [Abstract][Full Text] [Related]
16. Cell-penetrating peptides and peptide nucleic acid-coupled MRI contrast agents: evaluation of cellular delivery and target binding.
Mishra R; Su W; Pohmann R; Pfeuffer J; Sauer MG; Ugurbil K; Engelmann J
Bioconjug Chem; 2009 Oct; 20(10):1860-8. PubMed ID: 19788302
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel peptide ligand of human transfrrin receptor 1 for targeted tumor delivery drug.
Xin Q; Cun Z; Xiaochang X; Meng L; Weina L; Qiang H; Yingqi Z; Zhen Y; Wei Z
Protein Pept Lett; 2013 Jan; 20(1):96-101. PubMed ID: 22670765
[TBL] [Abstract][Full Text] [Related]
18. A peptide conjugate of vitamin E succinate targets breast cancer cells with high ErbB2 expression.
Wang XF; Birringer M; Dong LF; Veprek P; Low P; Swettenham E; Stantic M; Yuan LH; Zobalova R; Wu K; Ledvina M; Ralph SJ; Neuzil J
Cancer Res; 2007 Apr; 67(7):3337-44. PubMed ID: 17409443
[TBL] [Abstract][Full Text] [Related]
19. Selection of chronic lymphocytic leukemia binding peptides.
Takahashi S; Mok H; Parrott MB; Marini FC; Andreeff M; Brenner MK; Barry MA
Cancer Res; 2003 Sep; 63(17):5213-7. PubMed ID: 14500347
[TBL] [Abstract][Full Text] [Related]
20. Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display.
Lee SM; Lee EJ; Hong HY; Kwon MK; Kwon TH; Choi JY; Park RW; Kwon TG; Yoo ES; Yoon GS; Kim IS; Ruoslahti E; Lee BH
Mol Cancer Res; 2007 Jan; 5(1):11-9. PubMed ID: 17259343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
